
    
      Each participant will receive each of the formulations in a crossover design. Part A Periods
      1 and 2: Participants will receive either samatasvir capsules or tablets according to
      randomization under fasting conditions on Days 1 and 8. Part A Period 3: All participants
      will receive samatasvir tablets under fed conditons on Day 15.

      Each dose will be separated by a 7-day wash-out period. Part B: All participants will receive
      samatasvir capsules under fed conditons on Day 1.
    
  